Pharmacy Department, Qinhuai Medical District, General Hospital of Eastern Theater Command, Nanjing, Jiangsu, 210001, China.
Wenzhou Center for Disease Control and Prevention, Wenzhou, Zhejiang, 325000, China.
Chem Biodivers. 2023 May;20(5):e202201228. doi: 10.1002/cbdv.202201228. Epub 2023 Apr 25.
Guizhi granules mainly treat colds and improve overall health. They are widely used in clinical practice, but their protective effect and anti-inflammatory mechanism against influenza are unclear. In this study, the therapeutic effect of Guizhi granules on influenza was verified in vitro. The active compounds, targets, and cellular pathways of Guizhi granules against influenza were predicted using network pharmacology. The protein-protein interaction and component-target networks identified 5 core targets (JUN, TNF-α, RELA, AKT1, and MAPK1) and components (dihydrocapsaicin, kumatakenin, calycosin, licochalcone A, and berberine). GO and KEGG enrichment analyses revealed the anti-influenza pathways of Guizhi granules as antiviral and anti-inflammatory pathways. Molecular docking further verified that the core targets and components have good or strong binding activity. Therefore, the active ingredients, targets, and molecular mechanisms of Guizhi granules involved in influenza treatment were elucidated.
桂枝颗粒主要治疗感冒,提高整体健康水平。它们在临床实践中得到广泛应用,但它们对流感的保护作用和抗炎机制尚不清楚。本研究通过体外实验验证了桂枝颗粒对流感的治疗作用。利用网络药理学预测了桂枝颗粒治疗流感的活性成分、靶点和细胞通路。蛋白质-蛋白质相互作用和成分-靶点网络确定了 5 个核心靶点(JUN、TNF-α、RELA、AKT1 和 MAPK1)和成分(二氢辣椒素、苦参酮、大豆素、甘草素 A 和小檗碱)。GO 和 KEGG 富集分析显示,桂枝颗粒的抗流感途径为抗病毒和抗炎途径。分子对接进一步验证了核心靶点和成分具有良好或较强的结合活性。因此,阐明了桂枝颗粒治疗流感涉及的活性成分、靶点和分子机制。